Detalhe da pesquisa
1.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 69(6): 2165-2174, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594435
2.
Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease.
Scand J Gastroenterol
; 56(2): 155-161, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300822
3.
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system.
Pharmacoepidemiol Drug Saf
; 30(4): 520-524, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219593
4.
Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study.
Eur J Gastroenterol Hepatol
; 35(3): 261-269, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708296
5.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(4): 343-355, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736339
6.
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.
J Crohns Colitis
; 17(5): 738-745, 2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521000
7.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
J Crohns Colitis
; 17(11): 1771-1780, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310877
8.
De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation.
Eur J Gastroenterol Hepatol
; 34(5): 488-495, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34974465
9.
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.
Inflamm Bowel Dis
; 28(12): 1813-1820, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134917
10.
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.
United European Gastroenterol J
; 9(8): 919-928, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077634
11.
Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.
Drug Saf
; 44(5): 581-588, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538994
12.
Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease.
J Crohns Colitis
; 10(2): 159-65, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503525
13.
Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability.
PLoS One
; 8(3): e60435, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23544139
14.
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis.
Dig Liver Dis
; 43(2): 110-5, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20739231
15.
Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms.
J Crohns Colitis
; 3(2): 115-24, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21172254
16.
Time-resolved fluorimetric immunoassay of calprotectin: technical and clinical aspects in diagnosis of inflammatory bowel diseases.
Clin Chem Lab Med
; 44(3): 292-8, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16519601
17.
Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
Dis Colon Rectum
; 48(4): 758-67, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15750797
18.
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease.
J Clin Immunol
; 22(5): 281-8, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12405161